MIR4494

Across TCGA pan-cancer cohorts, MIR4494 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR4494 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher MIR4494 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4494 expression acts as an unfavorable survival marker, although some lineages such as COAD and SKCM show a favorable association.

LIHC, CHOL, and ACC are the cancer types where MIR4494 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	III,IV	0.092	0.649	<.001	72	view →
CHOL	OS	Tertile	All	0.133	0.743	<.001	54	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
DLBC	OS	Quartile	All	0.551	1.000	.006	36	view →
UCEC	OS	Tertile	III,IV	0.082	0.830	<.001	36	view →
BRCA	DFS	Tertile	All	0.876	0.951	.007	30	view →
COAD	DFS	Tertile	II,III,IV	0.937	0.645	.017	27	view →
LGG	OS	Tertile	All	0.602	0.898	<.001	27	view →
HNSC	DFS	Tertile	II,III,IV	0.165	0.563	.002	27	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
PCPG	OS	Tertile	All	0.524	0.975	<.001	18	view →
BLCA	DFS	Tertile	IV	0.217	0.500	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR4494–LIHC (OS)

Open the LIHC breakdown →